Combined intercellular and basement membrane zone deposits in pemphigus: Frequency and implications.

References:

• Schmidt E, Kasperkiewicz M, Joly P. Pemphigus. Lancet. 2019;394:882–894.
• Antiga E, Bech R, Maglie R, Genovese G, Borradori L, Bockle B, et al. S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2023;37:1118–1134.
• Grootenboer‐Mignot S, Descamps V, Picard‐Dahan C, Nicaise‐Roland P, Prost‐Squarcioni C, Leroux‐Villet C, et al. Place of human amniotic membrane immunoblotting in the diagnosis of autoimmune bullous dermatoses: placental amnion immunoblotting and autoimmune bullous dermatoses. Br J Dermatol. 2010;162(4):743–750. https://doi.org/10.1111/j.1365‐2133.2009.09566.x
• Leger S, Picard D, Ingen‐Housz‐Oro S, Arnault JP, Aubin F, Carsuzaa F, et al. Prognostic factors of paraneoplastic pemphigus. Arch Dermatol. 2012;148:1165.
• Kaplan I, Hodak E, Ackerman L, Mimouni D, Anhalt GJ, Calderon S. Neoplasms associated with paraneoplastic pemphigus: a review with emphasis on non‐hematologic malignancy and oral mucosal manifestations. Oral Oncol. 2004;40:553–562.